Literature DB >> 7592656

Deficient geranylgeranylation of Ram/Rab27 in choroideremia.

M C Seabra1, Y K Ho, J S Anant.   

Abstract

Choroideremia, an X-linked form of retinal degeneration, results from defects in the Rab escort protein-1 (REP-1) gene. REP-1 and REP-2 assist in the attachment of geranylgeranyl groups to Rab GTPases, a modification essential for their action as molecular switches regulating intracellular vesicular transport. If Rabs that depend preferentially on REP-1 for prenylation exist, they will accumulate unprenylated in choroideremia cells. Using recombinant Rab geranylgeranyl transferase and REPs to label unprenylated cytosolic proteins, we identified one unprenylated protein in choroideremia lymphoblasts that was prenylated in vitro more efficiently by REP-1 than by REP-2. This protein was purified and identified as Ram (renamed Rab27), a previously cloned Rab of unknown function. Immunohistochemistry of rat retina showed that Ram/Rab27 is expressed in the pigment epithelium and choriocapillaris, the two retinal cell layers that degenerate earliest in choroideremia. These results raise the possibility that the retinal degeneration in choroideremia results from the deficient geranylgeranylation of Ram/Rab27 or a closely related protein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7592656     DOI: 10.1074/jbc.270.41.24420

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  71 in total

1.  Retrospective, longitudinal, and cross sectional study of visual acuity impairment in choroideraemia.

Authors:  M Flynn Roberts; G A Fishman; D K Roberts; J R Heckenlively; R G Weleber; R J Anderson; S Grover
Journal:  Br J Ophthalmol       Date:  2002-06       Impact factor: 4.638

2.  A general role for Rab27a in secretory cells.

Authors:  Tanya Tolmachova; Ross Anders; Jane Stinchcombe; Giovanna Bossi; Gillian M Griffiths; Clare Huxley; Miguel C Seabra
Journal:  Mol Biol Cell       Date:  2003-11-14       Impact factor: 4.138

3.  Munc13-4 is an effector of rab27a and controls secretion of lysosomes in hematopoietic cells.

Authors:  Maaike Neeft; Marnix Wieffer; Arjan S de Jong; Gabriela Negroiu; Corina H G Metz; Alexander van Loon; Janice Griffith; Jeroen Krijgsveld; Nico Wulffraat; Henriette Koch; Albert J R Heck; Nils Brose; Monique Kleijmeer; Peter van der Sluijs
Journal:  Mol Biol Cell       Date:  2004-11-17       Impact factor: 4.138

4.  Molecular evolution of the Rab-escort-protein/guanine-nucleotide-dissociation-inhibitor superfamily.

Authors:  Christelle Alory; William E Balch
Journal:  Mol Biol Cell       Date:  2003-05-29       Impact factor: 4.138

Review 5.  TLRs and innate immunity.

Authors:  Bruce A Beutler
Journal:  Blood       Date:  2008-08-29       Impact factor: 22.113

Review 6.  Rab GTPases as coordinators of vesicle traffic.

Authors:  Harald Stenmark
Journal:  Nat Rev Mol Cell Biol       Date:  2009-07-15       Impact factor: 94.444

7.  Clinical findings in a choroideremia patient who underwent vitrectomy for retinal detachment associated with macular hole.

Authors:  Hajime Shinoda; Takashi Koto; Keiko Fujiki; Akira Murakami; Kazuo Tsubota; Yoko Ozawa
Journal:  Jpn J Ophthalmol       Date:  2011-03-13       Impact factor: 2.447

Review 8.  Role of Rab GTPases in membrane traffic and cell physiology.

Authors:  Alex H Hutagalung; Peter J Novick
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

9.  The retinitis pigmentosa GTPase regulator, RPGR, interacts with the delta subunit of rod cyclic GMP phosphodiesterase.

Authors:  M Linari; M Ueffing; F Manson; A Wright; T Meitinger; J Becker
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

10.  Functional redundancy of Rab27 proteins and the pathogenesis of Griscelli syndrome.

Authors:  Duarte C Barral; José S Ramalho; Ross Anders; Alistair N Hume; Holly J Knapton; Tanya Tolmachova; Lucy M Collinson; David Goulding; Kalwant S Authi; Miguel C Seabra
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.